Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
Clinical trial NCT02271945 · COMPLETED
Trial details
- NCT number
- NCT02271945
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-05-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.